BOYDSense, a Serpentine Ventures portfolio company, was selected by the European Innovation Council (EISMEA) to pitch at the HealthTech Investor Day in Paris. This recognition highlights their innovation in diabetes tech.
BOYDSense, a Serpentine Ventures portfolio company, was selected by the European Innovation Council (EISMEA) to pitch at the HealthTech Investor Day in Paris. This recognition highlights their innovation in diabetes tech.
